Deferoxamine Mesylate

NDC 0409-2337 · Hospira, Inc.

Generic nameDeferoxamine Mesylate

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS

Active ingredient(s)DEFEROXAMINE MESYLATE

Strength2 g/1

Pharmacologic classIron Chelating Activity [MoA], Iron Chelator [EPC]

Marketing categoryANDA

Packages

0409-2337-25 — 4 VIAL, SINGLE-USE in 1 CARTON (0409-2337-25) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE (0409-2337-15)

J0895 — Injection, deferoxamine mesylate, 500 mg Medicare Part B payment limit (ASP + 6%): $10.02

FDA lists these products with the same active ingredient.

0078-0467 — deferoxamine mesylate, 60505-6236 — Deferoxamine mesylate, 60505-6237 — Deferoxamine mesylate, 63323-597 — DEFEROXAMINE MESYLATE, 63323-599 — DEFEROXAMINE MESYLATE, 68083-172 — Deferoxamine mesylate, 68083-173 — Deferoxamine mesylate, 87081-467 — deferoxamine mesylate

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.